{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:41:09Z","timestamp":1790404869487,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T00:00:00Z","timestamp":1526515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s13577-018-0212-3","type":"journal-article","created":{"date-parts":[[2018,5,17]],"date-time":"2018-05-17T03:30:02Z","timestamp":1526527802000},"page":"261-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["HuH-7 reference genome profile: complex karyotype composed of massive loss of heterozygosity"],"prefix":"10.1007","volume":"31","author":[{"given":"Fumio","family":"Kasai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonobu","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arihiro","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,17]]},"reference":[{"key":"212_CR1","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/jnci\/djt007","volume":"105","author":"JP Gillet","year":"2013","unstructured":"Gillet JP, Varma S, Gottesman MM. The clinical relevance of cancer cell lines. J Natl Cancer Inst. 2013;105:452\u20138. \n                    https:\/\/doi.org\/10.1093\/jnci\/djt007\n                    \n                  .","journal-title":"J Natl Cancer Inst"},{"key":"212_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. \n                    https:\/\/doi.org\/10.1016\/j.cell.2011.02.013\n                    \n                  .","journal-title":"Cell"},{"key":"212_CR3","doi-asserted-by":"publisher","first-page":"4767","DOI":"10.1038\/ncomms5767","volume":"5","author":"YC Lin","year":"2014","unstructured":"Lin YC, Boone M, Meuris L, Lemmens I, Van Roy N, Soete A, Reumers J, Moisse M, Plaisance S, Drmanac R, Chen J, Speleman F, Lambrechts D, Van de Peer Y, Tavernier J, Callewaert N. Genome dynamics of the human embryonic kidney 293 lineage in response to cell biology manipulations. Nat Commun. 2014;5:4767. \n                    https:\/\/doi.org\/10.1038\/ncomms5767\n                    \n                  .","journal-title":"Nat Commun"},{"key":"212_CR4","first-page":"3858","volume":"42","author":"H Nakabayashi","year":"1982","unstructured":"Nakabayashi H, Taketa K, Yamane T, Miyazaki M, Miyano K, Sato J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 1982;42:3858\u201363.","journal-title":"Cancer Res"},{"key":"212_CR5","first-page":"151","volume":"75","author":"H Nakabayashi","year":"1984","unstructured":"Nakabayashi H, Taketa K, Yamane T, Miyazaki M, Miyano K, Sato J. Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. Gan. 1984;75:151\u20138.","journal-title":"Gan"},{"key":"212_CR6","first-page":"6379","volume":"45","author":"H Nakabayashi","year":"1985","unstructured":"Nakabayashi H, Taketa K, Yamane T, Oda M, Sato J. Hormonal control of alpha-fetoprotein secretion in human hepatoma cell lines proliferating in chemically defined medium. Cancer Res. 1985;45:6379\u201383.","journal-title":"Cancer Res"},{"key":"212_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1126\/science.285.5424.110","volume":"285","author":"V Lohmann","year":"1999","unstructured":"Lohmann V, K\u00f6rner F, Koch J, Herian U, Theilmann L, Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 1999;285:110\u20133.","journal-title":"Science"},{"key":"212_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1541-7786.MCR-15-0189","volume":"14","author":"A Goodspeed","year":"2016","unstructured":"Goodspeed A, Heiser LM, Gray JW, Costello JC. Tumor-derived cell lines as molecular models of cancer pharmacogenomics. Mol Cancer Res. 2016;14:3\u201313. \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-15-0189\n                    \n                  .","journal-title":"Mol Cancer Res"},{"key":"212_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ygeno.2016.04.003","volume":"107","author":"F Kasai","year":"2016","unstructured":"Kasai F, Hirayama N, Ozawa M, Iemura M, Kohara A. Changes of heterogeneous cell populations in the Ishikawa cell line during long-term culture: Proposal for an in vitro clonal evolution model of tumor cells. Genomics. 2016;107:259\u201366. \n                    https:\/\/doi.org\/10.1016\/j.ygeno.2016.04.003\n                    \n                  .","journal-title":"Genomics"},{"key":"212_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11626-016-0126-x","volume":"53","author":"M Arul","year":"2017","unstructured":"Arul M, Roslani AC, Cheah SH. Heterogeneity in cancer cells: variation in drug response in different primary and secondary colorectal cancer cell lines in vitro. In Vitro Cell Dev Biol Anim. 2017;53:435\u201347. \n                    https:\/\/doi.org\/10.1007\/s11626-016-0126-x\n                    \n                  .","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"212_CR11","doi-asserted-by":"publisher","first-page":"13001","DOI":"10.1128\/JVI.76.24.13001-13014.2002","volume":"76","author":"KJ Blight","year":"2002","unstructured":"Blight KJ, McKeating JA, Rice CM. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J Virol. 2002;76:13001\u201314.","journal-title":"J Virol"},{"key":"212_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10616-017-0119-y","volume":"70","author":"S Shioda","year":"2018","unstructured":"Shioda S, Kasai F, Ozawa M, Hirayama N, Satoh M, Kameoka Y, Watanabe K, Shimizu N, Tang H, Mori Y, Kohara A. The human vascular endothelial cell line HUV-EC-C harbors the integrated HHV-6B genome which remains stable in long term culture. Cytotechnology. 2018;70:141\u201352. \n                    https:\/\/doi.org\/10.1007\/s10616-017-0119-y\n                    \n                  .","journal-title":"Cytotechnology"},{"key":"212_CR13","doi-asserted-by":"publisher","first-page":"992","DOI":"10.7150\/ijbs.4454","volume":"8","author":"Y Chen","year":"2012","unstructured":"Chen Y, Yu D, Zhang H, He H, Zhang C, Zhao W, Shao RG. CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells. Int J Biol Sci. 2012;8:992\u20131004. \n                    https:\/\/doi.org\/10.7150\/ijbs.4454\n                    \n                  .","journal-title":"Int J Biol Sci"},{"key":"212_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-11-251","volume":"11","author":"J Zheng","year":"2011","unstructured":"Zheng J, Li Y, Yang J, Liu Q, Shi M, Zhang R, Shi H, Ren Q, Ma J, Guo H, Tao Y, Xue Y, Jiang N, Yao L, Liu W. NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression. BMC Cancer. 2011;11:251:1\u20139. \n                    https:\/\/doi.org\/10.1186\/1471-2407-11-251\n                    \n                  .","journal-title":"BMC Cancer"},{"key":"212_CR15","doi-asserted-by":"publisher","first-page":"9525","DOI":"10.18632\/oncotarget.6672","volume":"7","author":"J Luo","year":"2016","unstructured":"Luo J, Wang P, Wang R, Wang J, Liu M, Xiong S, Li Y, Cheng B. The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinoma. Oncotarget. 2016;7:9525\u201337. \n                    https:\/\/doi.org\/10.18632\/oncotarget.6672\n                    \n                  .","journal-title":"Oncotarget"},{"key":"212_CR16","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s001090100244","volume":"79","author":"M Volkmann","year":"2001","unstructured":"Volkmann M, Schiff JH, Hajjar Y, Otto G, Stilgenbauer F, Fiehn W, Galle PR, Hofmann WJ. Loss of CD95 expression is linked to most but not all p53 mutants in European hepatocellular carcinoma. J Mol Med (Berl). 2001;79:594\u2013600.","journal-title":"J Mol Med (Berl)"},{"key":"212_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s11626-017-0177-7","volume":"53","author":"JM Baust","year":"2017","unstructured":"Baust JM, Buehring GC, Campbell L, Elmore E, Harbell JW, Nims RW, Price P, Reid YA, Simione F. Best practices in cell culture: an overview. In Vitro Cell Dev Biol Anim. 2017;53:669\u201372. \n                    https:\/\/doi.org\/10.1007\/s11626-017-0177-7\n                    \n                  .","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"212_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.stem.2012.11.011","volume":"12","author":"Q Ding","year":"2013","unstructured":"Ding Q, Lee YK, Schaefer EA, et al. A TALEN genome-editing system for generating human stem cell-based disease models. Cell Stem Cell. 2013;12:238\u201351. \n                    https:\/\/doi.org\/10.1016\/j.stem.2012.11.011\n                    \n                  .","journal-title":"Cell Stem Cell"},{"key":"212_CR19","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/ng1215","volume":"34","author":"DG Albertson","year":"2003","unstructured":"Albertson DG, Collins C, McCormick F, Gray JW. Chromosome aberrations in solid tumors. Nat Genet. 2003;34:369\u201376.","journal-title":"Nat Genet"},{"key":"212_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/dnares\/dsy007","author":"F Kasai","year":"2018","unstructured":"Kasai F, Pereira JC, Kohara A, Ferguson-Smith MA. Homologue-specific chromosome sequencing characterizes translocation junctions and permits allelic assignment. DNA Res 2018. \n                    https:\/\/doi.org\/10.1093\/dnares\/dsy007\n                    \n                  . (Epub ahead of print).","journal-title":"DNA Res"},{"key":"212_CR21","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1101\/gr.191098.115","volume":"25","author":"NE Navin","year":"2015","unstructured":"Navin NE. The first five years of single-cell cancer genomics and beyond. Genome Res. 2015;25:1499\u2013507. \n                    https:\/\/doi.org\/10.1101\/gr.191098.115\n                    \n                  .","journal-title":"Genome Res"},{"key":"212_CR22","doi-asserted-by":"publisher","first-page":"10001","DOI":"10.1038\/ncomms10001","volume":"6","author":"TS Alioto","year":"2015","unstructured":"Alioto TS, Buchhalter I, Derdak S, et al. A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing. Nat Commun. 2015;6:10001. \n                    https:\/\/doi.org\/10.1038\/ncomms10001\n                    \n                  .","journal-title":"Nat Commun"},{"key":"212_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina J, Caponigro G, Stransky N, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483:603\u20137. \n                    https:\/\/doi.org\/10.1038\/nature11003\n                    \n                  .","journal-title":"Nature"},{"key":"212_CR24","doi-asserted-by":"publisher","first-page":"D777-D783","DOI":"10.1093\/nar\/gkw1121","volume":"45","author":"SA Forbes","year":"2017","unstructured":"Forbes SA, Beare D, Boutselakis H, et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 2017;45:D777-D783. \n                    https:\/\/doi.org\/10.1093\/nar\/gkw1121\n                    \n                  .","journal-title":"Nucleic Acids Res"},{"key":"212_CR25","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.1158\/0008-5472.CAN-14-1020","volume":"74","author":"AM Hudson","year":"2014","unstructured":"Hudson AM, Yates T, Li Y, Trotter EW, Fawdar S, Chapman P, Lorigan P, Biankin A, Miller CJ, Brognard J. Discrepancies in cancer genomic sequencing highlight opportunities for driver mutation discovery. Cancer Res. 2014;74:6390\u20136. \n                    https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-1020\n                    \n                  .","journal-title":"Cancer Res"},{"key":"212_CR26","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10577-010-9179-y","volume":"19","author":"SL Thompson","year":"2011","unstructured":"Thompson SL, Compton DA. Chromosomes and cancer cells. Chromosome Res. 2011;19:433\u201344. \n                    https:\/\/doi.org\/10.1007\/s10577-010-9179-y\n                    \n                  .","journal-title":"Chromosome Res"},{"key":"212_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12920-015-0123-z","volume":"8","author":"GL Ryland","year":"2015","unstructured":"Ryland GL, Doyle MA, Goode D, Boyle SE, Choong DY, Rowley SM, Li J; Australian Ovarian Cancer Study Group, Bowtell DD, Tothill RW, Campbell IG, Gorringe KL. Loss of heterozygosity: what is it good for? BMC Med Genom. 2015;8:45. \n                    https:\/\/doi.org\/10.1186\/s12920-015-0123-z\n                    \n                  .","journal-title":"BMC Med Genom"},{"key":"212_CR28","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1158\/1541-7786.MCR-08-0035","volume":"6","author":"S Ma","year":"2008","unstructured":"Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, Guan XY. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res. 2008;6:1146\u201353. \n                    https:\/\/doi.org\/10.1158\/1541-7786.MCR-08-0035\n                    \n                  .","journal-title":"Mol Cancer Res"},{"key":"212_CR29","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1073\/pnas.0307618100","volume":"101","author":"T Kondo","year":"2004","unstructured":"Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA. 2004;101:781\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"212_CR30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.4161\/cc.3.4.795","volume":"3","author":"T Setoguchi","year":"2004","unstructured":"Setoguchi T, Taga T, Kondo T. Cancer stem cells persist in many cancer cell lines. Cell Cycle. 2004;3:414\u20135.","journal-title":"Cell Cycle"},{"key":"212_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3233\/CBM-2007-34-508","volume":"3","author":"T Kondo","year":"2007","unstructured":"Kondo T. Stem cell-like cancer cells in cancer cell lines. Cancer Biomark. 2007;3:245 \u2013 50.","journal-title":"Cancer Biomark"},{"key":"212_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nmeth.3403","volume":"12","author":"LP Freedman","year":"2015","unstructured":"Freedman LP, Gibson MC, Ethier SP, Soule HR, Neve RM, Reid YA. Reproducibility: changing the policies and culture of cell line authentication. Nat Methods. 2015;12:493\u20137. \n                    https:\/\/doi.org\/10.1038\/nmeth.3403\n                    \n                  .","journal-title":"Nat Methods"},{"key":"212_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature12831","volume":"504","author":"B Haibe-Kains","year":"2013","unstructured":"Haibe-Kains B, El-Hachem N, Birkbak NJ, Jin AC, Beck AH, Aerts HJ, Quackenbush J. Inconsistency in large pharmacogenomic studies. Nature. 2013;504:389\u201393. \n                    https:\/\/doi.org\/10.1038\/nature12831\n                    \n                  .","journal-title":"Nature"},{"key":"212_CR34","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1007\/s11626-017-0212-8","volume":"53","author":"RW Nims","year":"2017","unstructured":"Nims RW, Reid Y. Best practices for authenticating cell lines. In Vitro Cell Dev Biol Anim. 2017;53:880\u20137. \n                    https:\/\/doi.org\/10.1007\/s11626-017-0212-8\n                    \n                  .","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"212_CR35","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s11626-017-0199-1","volume":"53","author":"YA Reid","year":"2017","unstructured":"Reid YA. Best practices for naming, receiving, and managing cells in culture. In Vitro Cell Dev Biol Anim. 2017;53:761\u201374. \n                    https:\/\/doi.org\/10.1007\/s11626-017-0199-1\n                    \n                  .","journal-title":"In Vitro Cell Dev Biol Anim"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13577-018-0212-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-018-0212-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-018-0212-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T19:42:46Z","timestamp":1558035766000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13577-018-0212-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,17]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1007\/s13577-018-0212-3","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,17]]},"assertion":[{"value":"8 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}